Clomipramine

Generic name: Pronounced as (kloe mi' pra meen)
Brand names
  • Anafranil®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 09/15/2018

A small number of children, teenagers, and young adults (up to 24 years of age) who took antidepressants ('mood elevators') such as clomipramine during clinical studies became suicidal (thinking about harming or killing oneself or planning or trying to do so). Children, teenagers, and young adults who take antidepressants to treat depression or other mental illnesses may be more likely to become suicidal than children, teenagers, and young adults who do not take antidepressants to treat these conditions. However, experts are not sure about how great this risk is and how much it should be considered in deciding whether a child or teenager should take an antidepressant. Children younger than 18 years of age should not normally take clomipramine, but in some cases, a doctor may decide that clomipramine is the best medication to treat a child's condition.

You should know that your mental health may change in unexpected ways when you take clomipramine or other antidepressants even if you are an adult over age 24. You may become suicidal, especially at the beginning of your treatment and any time that your dose is increased or decreased. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: new or worsening depression; thinking about harming or killing yourself, or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; aggressive behavior; irritability; acting without thinking; severe restlessness; and frenzied abnormal excitement. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own.

Your healthcare provider will want to see you often while you are taking clomipramine, especially at the beginning of your treatment. Be sure to keep all appointments for office visits with your doctor.

The doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with clomipramine. Read the information carefully and ask your doctor or pharmacist if you have any questions. You also can obtain the Medication Guide from the FDA website: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/UCM096273.

No matter your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments. You should also talk about the risks and benefits of not treating your condition. You should know that having depression or another mental illness greatly increases the risk that you will become suicidal. This risk is higher if you or anyone in your family has or has ever had bipolar disorder (mood that changes from depressed to abnormally excited) or mania (frenzied, abnormally excited mood) or has thought about or attempted suicide. Talk to your doctor about your condition, symptoms, and personal and family medical history. You and your doctor will decide what type of treatment is right for you.

Clomipramine is used to treat people with obsessive-compulsive disorder (a condition that causes repeated unwanted thoughts and the need to perform certain behaviors over and over). Clomipramine is in a group of medications called tricyclic antidepressants. It works by increasing the amount of serotonin, a natural substance in the brain that is needed to maintain mental balance.

Clomipramine comes as a capsule to take by mouth. At the beginning of treatment, clomipramine is usually taken three times a day with meals as the body adjusts to the medication. After several weeks of treatment, clomipramine is usually taken once a day at bedtime. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take clomipramine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor may start you on a low dose of clomipramine and gradually increase your dose.

It may take several weeks or longer for you to feel the full benefit of clomipramine. Continue to take clomipramine even if you feel well. Do not stop taking clomipramine without talking to your doctor. If you suddenly stop taking clomipramine, you may experience withdrawal symptoms such as dizziness, nausea, vomiting, headache, weakness, sleep problems, fever, and irritability. Your doctor probably will decrease your dose gradually.

Before taking clomipramine,

  • tell your doctor and pharmacist if you are allergic to clomipramine, other tricyclic antidepressants such as amitriptyline (Elavil), amoxapine (Asendin), desipramine (Norpramin), doxepin (Adapin, Sinequan), imipramine (Tofranil), nortriptyline (Aventyl, Pamelor), protriptyline (Vivactil), and trimipramine (Surmontil); any other medications, or any of the inactive ingredients in clomipramine capsules. Ask your doctor or pharmacist for a list of the inactive ingredients.

  • tell your doctor if you are taking a monoamine oxidase (MAO) inhibitor such as isocarboxazid (Marplan), linezolid (Zyvox), methylene blue, phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar), and tranylcypromine (Parnate), or if you have stopped taking an MAO inhibitor within the past 14 days. Your doctor will probably tell you not to take clomipramine. If you stop taking clomipramine, you should wait at least 14 days before you start to take an MAO inhibitor.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); benztropine (Cogentin); cimetidine (Tagamet); clonidine (Catapres); dicyclomine (Bentyl); digoxin (Lanoxin); disulfiram; flecainide (Tambocor); guanethidine (Ismelin); haloperidol (Haldol); levodopa (Sinemet, Dopar); medications for nausea, dizziness, or mental illness; methylphenidate (Concerta, Metadate, Ritalin); oral contraceptives; phenobarbital; phenytoin; propafenone (Rythmol); quinidine; secobarbital (Seconal); sedatives; selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (Prozac, Sarafem), sertraline (Zoloft), and paroxetine (Paxil); tranquilizers; and trihexyphenidyl (Artane); and vitamins. Your doctor may need to change the doses of your medication or monitor you more carefully for side effects. Your doctor may tell you not to take clomipramine if you have stopped taking fluoxetine during the past 5 weeks.

  • tell your doctor if you have recently had a heart attack. Your doctor may tell you that you should not take clomipramine.

  • tell your doctor if you are being treated with electroshock therapy (procedure in which small electric shocks are administered to the brain to treat certain mental illnesses), if you drink or have ever drunk large amounts of alcohol and if you have or have ever had seizures, brain damage, problems with your urinary system or prostate (a male reproductive organ), irregular heartbeat, problems with your blood pressure, thyroid problems, or heart, kidney, or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking clomipramine, call your doctor.

  • talk to your doctor about the risks and benefits of taking clomipramine if you are 65 years of age or older. Older adults should not usually take clomipramine because it is not as safe or effective as other medications that can be used to treat the same condition.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking clomipramine.

  • you should know that this medication may make you drowsy and may increase the risk that you will have a seizure. Do not drive a car, operate machinery, swim, or climb until you know how this medication affects you.

  • remember that alcohol can add to the drowsiness caused by this medication.

  • tell your doctor if you use tobacco products. Cigarette smoking may decrease the effectiveness of this medication.

  • you should know that clomipramine may cause angle-closure glaucoma (a condition where the fluid is suddenly blocked and unable to flow out of the eye causing a quick, severe increase in eye pressure which may lead to a loss of vision). Talk to your doctor about having an eye examination before you start taking this medication. If you have nausea, eye pain, changes in vision, such as seeing colored rings around lights, and swelling or redness in or around the eye, call your doctor or get emergency medical treatment right away.

Unless your doctor tells you otherwise, continue your usual diet.

Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Clomipramine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • drowsiness

    • dry mouth

    • nausea

    • vomiting

    • diarrhea

    • constipation

    • nervousness

    • decreased sexual ability

    • decreased memory or concentration

    • headache

    • stuffy nose

    • change in appetite or weight

  • Some side effects may be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING or SPECIAL PRECAUTIONS sections, call your doctor immediately or get emergency medical treatment:

    • uncontrollable shaking of a part of the body

    • seizures

    • fast, irregular, or pounding heartbeat

    • difficulty urinating or loss of bladder control

    • believing things that are not true

    • hallucinations (seeing things or hearing voices that do not exist)

    • shakiness

    • difficulty breathing or fast breathing

    • severe muscle stiffness

    • unusual tiredness or weakness

    • sore throat, fever, and other signs of infection

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • seizures

  • coma (loss of consciousness for a period of time)

  • drowsiness

  • restlessness

  • loss of coordination

  • sweating

  • stiff muscles

  • unusual movements

  • fast heartbeat

  • slowed breathing

  • blue discoloration of the skin

  • fever

  • widened pupils (dark circles in the center of the eye)

  • decreased urination

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Clomipramine can be decreased when combined with Moxifloxacin.
Repaglinide Repaglinide Clomipramine may decrease the hypoglycemic activities of Repaglinide.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Clomipramine can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Clomipramine can be decreased when it is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Clomipramine can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Clomipramine can be decreased when combined with Nevirapine.
Dolasetron Dolasetron The metabolism of Clomipramine can be decreased when combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Clomipramine can be decreased when combined with Aminophylline.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Anagrelide.
Candesartan Candesartan Clomipramine may decrease the antihypertensive activities of Candesartan.
Cilostazol Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Clomipramine.
Clopidogrel Clopidogrel The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Clomipramine resulting in a loss in efficacy.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Clomipramine.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Clomipramine can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Clomipramine can be decreased when combined with Conjugated estrogens.
Fenofibrate Fenofibrate The metabolism of Clomipramine can be decreased when combined with Fenofibrate.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Clomipramine is combined with Guanfacine.
Magnesium Hydroxide Magnesium Hydroxide Clomipramine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine The metabolism of Clomipramine can be decreased when combined with Methylergometrine.
Miglitol Miglitol Clomipramine may decrease the hypoglycemic activities of Miglitol.
Mycophenolate Mycophenolate Mycophenolic acid may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Clomipramine.
Olsalazine Olsalazine Clomipramine may decrease the excretion rate of Olsalazine which could result in a higher serum level.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Clomipramine.
Penbutolol Penbutolol The metabolism of Acebutolol can be decreased when combined with Clomipramine.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Clomipramine.
Potassium Potassium Potassium may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Ranitidine Ranitidine The metabolism of Clomipramine can be decreased when combined with Ranitidine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Clomipramine is combined with Reserpine.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Rizatriptan is combined with Clomipramine.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Clomipramine.
Tacrolimus Tacrolimus The metabolism of Clomipramine can be decreased when combined with Tacrolimus.
Tizanidine Tizanidine The metabolism of Clomipramine can be decreased when combined with Tizanidine.
Triamcinolone Triamcinolone The metabolism of Clomipramine can be increased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The metabolism of Clomipramine can be decreased when combined with Zolmitriptan.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection The metabolism of Clomipramine can be decreased when combined with Doxycycline.
Famotidine Injection Famotidine Injection The metabolism of Clomipramine can be decreased when combined with Famotidine.
Fluconazole Injection Fluconazole Injection The metabolism of Clomipramine can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Clomipramine.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Clomipramine.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Clomipramine can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Clomipramine can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The metabolism of Clomipramine can be decreased when combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Clomipramine can be increased when combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Clomipramine can be increased when combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Clomipramine.
Metronidazole Injection Metronidazole Injection The metabolism of Clomipramine can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Clomipramine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Clomipramine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine The therapeutic efficacy of Clomipramine can be increased when used in combination with Amphetamine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Cyclosporine Cyclosporine The metabolism of Clomipramine can be decreased when combined with Cyclosporine.
Ondansetron Ondansetron The metabolism of Clomipramine can be decreased when combined with Ondansetron.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Granisetron is combined with Clomipramine.
Torsemide Torsemide Clomipramine may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Clomipramine.
Alosetron Alosetron The metabolism of Clomipramine can be decreased when combined with Alosetron.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Dofetilide.
Entacapone Entacapone The metabolism of Clomipramine can be decreased when combined with Entacapone.
Eprosartan Eprosartan Clomipramine may decrease the antihypertensive activities of Eprosartan.
Hydroxychloroquine Hydroxychloroquine The metabolism of Clomipramine can be decreased when combined with Hydroxychloroquine.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Orlistat Orlistat The metabolism of Clomipramine can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Clomipramine can be increased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole The metabolism of Clomipramine can be decreased when combined with Pantoprazole.
Telmisartan Telmisartan The metabolism of Telmisartan can be decreased when combined with Clomipramine.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Zaleplon is combined with Clomipramine.
Anakinra Anakinra The metabolism of Clomipramine can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Clomipramine.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Clomipramine.
Trimipramine Trimipramine The metabolism of Clomipramine can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Clomipramine can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Clomipramine can be decreased when combined with Modafinil.
Perindopril Perindopril Clomipramine may decrease the antihypertensive activities of Perindopril.
Tenofovir Tenofovir The metabolism of Clomipramine can be decreased when combined with Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Clomipramine may decrease the excretion rate of Choline magnesium trisalicylate which could result in a higher serum level.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Clomipramine.
Epinephrine Injection Epinephrine Injection The metabolism of Clomipramine can be decreased when combined with Epinephrine.
Eplerenone Eplerenone Clomipramine may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Clomipramine.
Olmesartan Olmesartan Clomipramine may decrease the antihypertensive activities of Olmesartan.
Zonisamide Zonisamide The metabolism of Clomipramine can be decreased when combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Clomipramine can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Clomipramine.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Clomipramine.
Dexmethylphenidate Dexmethylphenidate The serum concentration of Clomipramine can be increased when it is combined with Dexmethylphenidate.
Atazanavir Atazanavir The metabolism of Clomipramine can be decreased when combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Clomipramine can be decreased when combined with Almotriptan.
Eletriptan Eletriptan The metabolism of Clomipramine can be decreased when combined with Eletriptan.
Mefloquine Mefloquine The metabolism of Clomipramine can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Clomipramine can be decreased when combined with Rosuvastatin.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Clomipramine.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Clomipramine.
Aprepitant Aprepitant The metabolism of Clomipramine can be decreased when combined with Aprepitant.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Clomipramine can be decreased when combined with Interferon beta-1a.
Memantine Memantine The metabolism of Clomipramine can be decreased when combined with Memantine.
Tegaserod Tegaserod The metabolism of Clomipramine can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Clomipramine may decrease the antihypertensive activities of Tadalafil.
Frovatriptan Frovatriptan The metabolism of Clomipramine can be decreased when combined with Frovatriptan.
Gemifloxacin Gemifloxacin The metabolism of Clomipramine can be decreased when combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Progesterone can be increased when combined with Clomipramine.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Clomipramine.
Infliximab Injection Infliximab Injection The metabolism of Clomipramine can be increased when combined with Infliximab.
Protriptyline Protriptyline The metabolism of Clomipramine can be decreased when combined with Protriptyline.
Rifaximin Rifaximin The metabolism of Clomipramine can be increased when combined with Rifaximin.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Clomipramine is combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Clomipramine can be increased when combined with Norethisterone.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Trospium Trospium The metabolism of Trospium can be decreased when combined with Clomipramine.
Bosentan Bosentan The metabolism of Bosentan can be increased when combined with Clomipramine.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Clomipramine can be decreased when combined with Cinacalcet.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Clomipramine can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Clomipramine is combined with Eszopiclone.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection Clomipramine may decrease the hypoglycemic activities of Insulin aspart.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Solifenacin Solifenacin The metabolism of Solifenacin can be decreased when combined with Clomipramine.
Valganciclovir Valganciclovir Clomipramine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Clomipramine.
Adefovir Adefovir Adefovir may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine The therapeutic efficacy of Clomipramine can be increased when used in combination with Amphetamine.
Entecavir Entecavir The metabolism of Clomipramine can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Clomipramine can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Clomipramine can be increased when it is combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection Clomipramine may decrease the hypoglycemic activities of Pramlintide.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Exenatide Injection Exenatide Injection Clomipramine may decrease the hypoglycemic activities of Exenatide.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Clomipramine.
Isocarboxazid Isocarboxazid Clomipramine may increase the serotonergic activities of Isocarboxazid.
Ramelteon Ramelteon The metabolism of Clomipramine can be decreased when combined with Ramelteon.
Darifenacin Darifenacin The metabolism of Clomipramine can be decreased when combined with Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Clomipramine.
Pregabalin Pregabalin The therapeutic efficacy of Clomipramine can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The serum concentration of Clomipramine can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine Clomipramine may increase the vasopressor activities of Phenylephrine.
Tipranavir Tipranavir The metabolism of Clomipramine can be decreased when combined with Tipranavir.
Felbamate Felbamate The metabolism of Clomipramine can be increased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection Clomipramine may decrease the hypoglycemic activities of Insulin detemir.
Ranolazine Ranolazine The serum concentration of Clomipramine can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Clomipramine can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the serotonergic activities of Clomipramine.
Imatinib Imatinib The metabolism of Clomipramine can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin Clomipramine may decrease the hypoglycemic activities of Sitagliptin.
Varenicline Varenicline Clomipramine may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The metabolism of Clomipramine can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of hypertension can be increased when Salbutamol is combined with Clomipramine.
Paliperidone Paliperidone The metabolism of Paliperidone can be decreased when combined with Clomipramine.
Bortezomib Bortezomib The metabolism of Clomipramine can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Clomipramine.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Clomipramine can be increased when combined with Insulin glulisine.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Clomipramine.
Posaconazole Posaconazole The metabolism of Clomipramine can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Clomipramine can be decreased when combined with Primaquine.
Aliskiren Aliskiren Clomipramine may decrease the antihypertensive activities of Aliskiren.
Bismuth Subsalicylate Bismuth Subsalicylate Clomipramine may increase the neurotoxic activities of Bismuth subsalicylate.
Darunavir Darunavir The serum concentration of Clomipramine can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection Pemetrexed may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Clomipramine.
Lisdexamfetamine Lisdexamfetamine The therapeutic efficacy of Clomipramine can be increased when used in combination with Lisdexamfetamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Clomipramine.
Sorafenib Sorafenib The metabolism of Clomipramine can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Clomipramine.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Clomipramine.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Clomipramine is combined with Levocetirizine.
Pegaptanib Injection Pegaptanib Injection Clomipramine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Clomipramine.
Mexiletine Mexiletine The metabolism of Clomipramine can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Clomipramine can be decreased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Azacitidine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Ivermectin Ivermectin The metabolism of Clomipramine can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The metabolism of Clomipramine can be decreased when combined with Temsirolimus.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Clomipramine can be decreased when combined with Nilotinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Toremifene is combined with Clomipramine.
Bexarotene Bexarotene The metabolism of Clomipramine can be increased when combined with Bexarotene.
Budesonide Budesonide The metabolism of Clomipramine can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Clomipramine can be decreased when combined with Chloramphenicol.
Desmopressin Desmopressin The risk or severity of hyponatremia and water intoxication can be increased when Clomipramine is combined with Desmopressin.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Clomipramine.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clomipramine.
Doripenem Injection Doripenem Injection Clomipramine may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The metabolism of Etravirine can be increased when combined with Clomipramine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Clomipramine.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Clomipramine can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Desvenlafaxine can be decreased when combined with Clomipramine.
Cevimeline Cevimeline The metabolism of Clomipramine can be decreased when combined with Cevimeline.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Clomipramine.
Tretinoin Tretinoin The metabolism of Clomipramine can be decreased when combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Clomipramine.
Pilocarpine Pilocarpine The metabolism of Clomipramine can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Clomipramine can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Clomipramine can be increased when combined with Certolizumab pegol.
Irinotecan Injection Irinotecan Injection The metabolism of Clomipramine can be decreased when combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Praziquantel Praziquantel The metabolism of Clomipramine can be decreased when combined with Praziquantel.
Mitotane Mitotane The metabolism of Clomipramine can be increased when combined with Mitotane.
Methylnaltrexone Injection Methylnaltrexone Injection Clomipramine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Clomipramine.
Midazolam Midazolam The metabolism of Clomipramine can be decreased when combined with Midazolam.
Naltrexone Injection Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Clomipramine.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Clomipramine.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Clomipramine is combined with Milnacipran.
Dexlansoprazole Dexlansoprazole The metabolism of Clomipramine can be decreased when combined with Dexlansoprazole.
Plerixafor Injection Plerixafor Injection Clomipramine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate The risk or severity of seizure can be increased when Clomipramine is combined with Sodium phosphate, monobasic.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Clomipramine.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Clomipramine.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Clomipramine.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Clomipramine.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Clomipramine.
Lacosamide Lacosamide The metabolism of Clomipramine can be decreased when combined with Lacosamide.
Everolimus Everolimus The metabolism of Clomipramine can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone Clomipramine may increase the QTc-prolonging activities of Dronedarone.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Clomipramine.
Pralatrexate Injection Pralatrexate Injection Clomipramine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection The metabolism of Clomipramine can be decreased when combined with Palonosetron.
Saxagliptin Saxagliptin Clomipramine may decrease the hypoglycemic activities of Saxagliptin.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Romidepsin.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Topotecan Topotecan The metabolism of Clomipramine can be increased when combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Clomipramine can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Clomipramine.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Clomipramine.
Albendazole Albendazole The metabolism of Clomipramine can be decreased when combined with Albendazole.
Oxymorphone Oxymorphone The metabolism of Clomipramine can be decreased when combined with Oxymorphone.
Liraglutide Injection Liraglutide Injection Clomipramine may decrease the hypoglycemic activities of Liraglutide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Clomipramine can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine The risk or severity of seizure can be increased when Dalfampridine is combined with Clomipramine.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Clomipramine.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Clomipramine.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Clomipramine is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Clomipramine can be increased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Clomipramine.
Ipilimumab Injection Ipilimumab Injection Clomipramine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Clomipramine can be decreased when combined with Aldesleukin.
Terbutaline Injection Terbutaline Injection The risk or severity of hypertension can be increased when Terbutaline is combined with Clomipramine.
Azilsartan Azilsartan The risk or severity of adverse effects can be increased when Clomipramine is combined with Azilsartan medoxomil.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Clomipramine.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Clomipramine.
Rilpivirine Rilpivirine The metabolism of Clomipramine can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The metabolism of Clomipramine can be decreased when combined with Glecaprevir.
Potassium Iodide Potassium Iodide The risk or severity of Cardiac Arrhythmia can be increased when Potassium Iodide is combined with Clomipramine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be increased when combined with Clomipramine.
Abiraterone Abiraterone The serum concentration of Clomipramine can be increased when it is combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Clomipramine.
Rivaroxaban Rivaroxaban Clomipramine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ticagrelor Ticagrelor The metabolism of Clomipramine can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Clomipramine can be decreased when combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib Clomipramine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Vandetanib.
Clobazam Clobazam The metabolism of Clomipramine can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Clomipramine can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Clomipramine can be decreased when combined with Vismodegib.
Ivacaftor Ivacaftor The metabolism of Clomipramine can be decreased when combined with Ivacaftor.
Deferiprone Deferiprone Clomipramine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Clomipramine can be decreased when combined with Axitinib.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Clomipramine.
Cabergoline Cabergoline The metabolism of Clomipramine can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Clomipramine can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan Clomipramine may decrease the antihypertensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Clomipramine.
Iloprost Iloprost The risk or severity of adverse effects can be increased when Iloprost is combined with Clomipramine.
Enzalutamide Enzalutamide The metabolism of Clomipramine can be increased when combined with Enzalutamide.
Mirabegron Mirabegron The serum concentration of Mirabegron can be increased when it is combined with Clomipramine.
Regorafenib Regorafenib The metabolism of Clomipramine can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Clomipramine can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Clomipramine can be increased when combined with Corticotropin.
Teriflunomide Teriflunomide The serum concentration of Clomipramine can be decreased when it is combined with Teriflunomide.
Lorcaserin Lorcaserin Clomipramine may decrease the hypoglycemic activities of Mecasermin.
Teduglutide Injection Teduglutide Injection Clomipramine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Bedaquiline.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Clomipramine.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Clomipramine.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Clomipramine.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Clomipramine can be decreased when combined with Trastuzumab emtansine.
Apixaban Apixaban The metabolism of Clomipramine can be decreased when combined with Apixaban.
Canagliflozin Canagliflozin Clomipramine may decrease the hypoglycemic activities of Canagliflozin.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The serum concentration of Clomipramine can be decreased when it is combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Clomipramine.
Trametinib Trametinib The metabolism of Trametinib can be increased when combined with Clomipramine.
Levomilnacipran Levomilnacipran The risk or severity of adverse effects can be increased when Clomipramine is combined with Levomilnacipran.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Clomipramine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Clomipramine.
Lomitapide Lomitapide The metabolism of Clomipramine can be decreased when combined with Lomitapide.
Avanafil Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Clomipramine.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Clomipramine is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Clomipramine can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir Clomipramine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Clomipramine can be decreased when combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Apremilast can be increased when combined with Clomipramine.
Droxidopa Droxidopa Clomipramine may increase the vasopressor activities of Droxidopa.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Clomipramine.
Siltuximab Injection Siltuximab Injection The metabolism of Clomipramine can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection Clomipramine may decrease the hypoglycemic activities of Albiglutide.
Eslicarbazepine Eslicarbazepine The metabolism of Eslicarbazepine can be increased when combined with Clomipramine.
Belinostat Injection Belinostat Injection The metabolism of Clomipramine can be increased when combined with Belinostat.
Idelalisib Idelalisib The metabolism of Clomipramine can be decreased when combined with Idelalisib.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be increased when combined with Clomipramine.
Oritavancin Injection Oritavancin Injection The metabolism of Clomipramine can be increased when combined with Oritavancin.
Empagliflozin Empagliflozin Clomipramine may decrease the hypoglycemic activities of Empagliflozin.
Vorapaxar Vorapaxar The metabolism of Clomipramine can be decreased when combined with Vorapaxar.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Suvorexant Suvorexant Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection Dulaglutide Injection Clomipramine may decrease the hypoglycemic activities of Dulaglutide.
Edoxaban Edoxaban Clomipramine may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Clomipramine can be decreased when combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Clomipramine can be decreased when combined with Olaparib.
Methamphetamine Methamphetamine The therapeutic efficacy of Clomipramine can be increased when used in combination with Metamfetamine.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Clomipramine.
Riociguat Riociguat Clomipramine may decrease the antihypertensive activities of Riociguat.
Lanreotide Injection Lanreotide Injection The metabolism of Clomipramine can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Clomipramine.
Nintedanib Nintedanib The metabolism of Clomipramine can be decreased when combined with Nintedanib.
Secukinumab Injection Secukinumab Injection The metabolism of Clomipramine can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Clomipramine may increase the hypotensive activities of Risperidone.
Palbociclib Palbociclib The metabolism of Clomipramine can be decreased when combined with Palbociclib.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Clomipramine can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The metabolism of Clomipramine can be increased when combined with Lenvatinib.
Naloxegol Naloxegol The metabolism of Clomipramine can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Clomipramine can be decreased when combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Clomipramine is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Clomipramine can be increased when it is combined with Haloperidol.
Ivabradine Ivabradine Ivabradine may increase the QTc-prolonging activities of Clomipramine.
Amiloride Amiloride Amiloride may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection Isavuconazonium Injection The metabolism of Clomipramine can be increased when combined with Isavuconazonium.
Macitentan Macitentan Clomipramine may decrease the antihypertensive activities of Macitentan.
Flibanserin Flibanserin The serum concentration of Flibanserin can be increased when it is combined with Clomipramine.
Rolapitant Rolapitant The metabolism of Clomipramine can be decreased when combined with Rolapitant.
Prednisolone Prednisolone The metabolism of Clomipramine can be increased when combined with Prednisolone.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Clomipramine.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Clomipramine.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Clomipramine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Clomipramine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Clomipramine is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Clomipramine can be increased when combined with Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Clomipramine can be decreased when combined with Cobimetinib.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Clomipramine.
Osimertinib Osimertinib The serum concentration of Clomipramine can be decreased when it is combined with Osimertinib.
Ixazomib Ixazomib Clomipramine may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Rifapentine Rifapentine The metabolism of Clomipramine can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Lesinurad can be increased when combined with Clomipramine.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Clomipramine can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Clomipramine can be increased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Clomipramine is combined with Brivaracetam.
Venetoclax Venetoclax The metabolism of Clomipramine can be decreased when combined with Venetoclax.
Cobicistat Cobicistat The metabolism of Clomipramine can be decreased when combined with Cobicistat.
Midodrine Midodrine Midodrine may increase the vasopressor activities of Clomipramine.
Selexipag Selexipag Clomipramine may decrease the antihypertensive activities of Selexipag.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Clomipramine is combined with Pimavanserin.
Obeticholic Acid Obeticholic Acid The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Clomipramine.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Clomipramine.
Furosemide Injection Furosemide Injection Clomipramine may decrease the excretion rate of Furosemide which could result in a higher serum level.
Rucaparib Rucaparib The metabolism of Clomipramine can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Clomipramine may decrease the hypoglycemic activities of Lixisenatide.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Clomipramine.
Brigatinib Brigatinib The metabolism of Clomipramine can be increased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Clomipramine.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Clomipramine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Clomipramine.
Deflazacort Deflazacort The metabolism of Clomipramine can be increased when combined with Deflazacort.
Safinamide Safinamide The metabolism of Safinamide can be decreased when combined with Clomipramine.
Naldemedine Naldemedine Clomipramine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The metabolism of Clomipramine can be increased when combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Clomipramine can be increased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Clomipramine can be decreased when combined with Enasidenib.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Clomipramine can be increased when combined with Fosaprepitant.
Benznidazole Benznidazole Clomipramine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Clomipramine.
Acalabrutinib Acalabrutinib The metabolism of Clomipramine can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The metabolism of Clomipramine can be decreased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection Clomipramine may decrease the hypoglycemic activities of Semaglutide.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Clomipramine.
Ertugliflozin Ertugliflozin Clomipramine may decrease the hypoglycemic activities of Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide The serum concentration of Clomipramine can be increased when it is combined with Apalutamide.
Fostamatinib Fostamatinib The metabolism of Clomipramine can be decreased when combined with Fostamatinib.
Baricitinib Baricitinib Clomipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Clomipramine can be increased when used in combination with Lofexidine.
Plazomicin Injection Plazomicin Injection Clomipramine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Clomipramine.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Clomipramine.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Clomipramine.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be increased when combined with Clomipramine.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Clomipramine.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Clomipramine.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clomipramine.
Dacomitinib Dacomitinib The metabolism of Clomipramine can be decreased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Clomipramine can be decreased when combined with Duvelisib.
Stiripentol Stiripentol The metabolism of Stiripentol can be decreased when combined with Clomipramine.
Gilteritinib Gilteritinib The therapeutic efficacy of Clomipramine can be decreased when used in combination with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Clomipramine.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Clomipramine.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Clomipramine can be increased when combined with Paclitaxel.
Rifamycin Rifamycin The metabolism of Clomipramine can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Clomipramine.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Clomipramine can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Clomipramine.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Clomipramine can be decreased when combined with Acyclovir.
Esomeprazole Injection Esomeprazole Injection The metabolism of Clomipramine can be decreased when combined with Esomeprazole.
Alpelisib Alpelisib The metabolism of Clomipramine can be increased when combined with Alpelisib.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Clomipramine is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Clomipramine.
Triclabendazole Triclabendazole The metabolism of Clomipramine can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Clomipramine.
Pitolisant Pitolisant The therapeutic efficacy of Pitolisant can be decreased when used in combination with Clomipramine.
Fedratinib Fedratinib The metabolism of Fedratinib can be decreased when combined with Clomipramine.
Lefamulin Lefamulin Clomipramine may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The metabolism of Clomipramine can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be increased when combined with Clomipramine.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Clomipramine.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Clomipramine.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Clomipramine is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Clomipramine is combined with Lasmiditan.
Tazemetostat Tazemetostat The metabolism of Clomipramine can be decreased when combined with Tazemetostat.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Clomipramine.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Clomipramine.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Clomipramine.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Clomipramine is combined with Selpercatinib.
Capmatinib Capmatinib The serum concentration of Clomipramine can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The serum concentration of Clomipramine can be decreased when it is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Clomipramine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Clomipramine.
Octreotide Octreotide The serum concentration of Clomipramine can be increased when it is combined with Octreotide.
Pralsetinib Pralsetinib The metabolism of Clomipramine can be increased when combined with Pralsetinib.
Opicapone Opicapone The metabolism of Clomipramine can be increased when combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Clomipramine can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Clomipramine is combined with Naxitamab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Clomipramine.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Clomipramine can be decreased when combined with Drospirenone.
Viloxazine Viloxazine The metabolism of Viloxazine can be decreased when combined with Clomipramine.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Clomipramine can be increased when combined with Vitamin E.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Clomipramine.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Indomethacin Indomethacin The metabolism of Clomipramine can be decreased when combined with Indomethacin.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Naproxen Naproxen The metabolism of Clomipramine can be decreased when combined with Naproxen.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Clomipramine.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Hydroxyurea Hydroxyurea The metabolism of Clomipramine can be decreased when combined with Hydroxyurea.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be increased when combined with Clomipramine.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Clomipramine.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Clomipramine.
Primidone Primidone The metabolism of Clomipramine can be increased when combined with Primidone.
Methsuximide Methsuximide The metabolism of Methsuximide can be decreased when combined with Clomipramine.
Diethylpropion Diethylpropion The therapeutic efficacy of Clomipramine can be increased when used in combination with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Clomipramine can be decreased when combined with Chlorpromazine.
Diazepam Diazepam The metabolism of Clomipramine can be decreased when combined with Diazepam.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Clomipramine.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Clomipramine.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Clomipramine.
Lorazepam Lorazepam The metabolism of Clomipramine can be decreased when combined with Lorazepam.
Phenoxybenzamine Phenoxybenzamine Clomipramine may decrease the antihypertensive activities of Phenoxybenzamine.
Carmustine Carmustine The metabolism of Clomipramine can be decreased when combined with Carmustine.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Clomipramine.
Codeine Codeine The metabolism of Clomipramine can be decreased when combined with Codeine.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Clomipramine.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Clomipramine.
Bromocriptine Bromocriptine The metabolism of Clomipramine can be decreased when combined with Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of hypertension can be increased when Clomipramine is combined with Orciprenaline.
Tranylcypromine Tranylcypromine The metabolism of Clomipramine can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Clomipramine can be decreased when combined with Phenelzine.
Procarbazine Procarbazine Procarbazine may increase the serotonergic activities of Clomipramine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clomipramine.
Tetracycline Tetracycline The metabolism of Clomipramine can be decreased when combined with Tetracycline.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Prochlorperazine Prochlorperazine The serum concentration of Clomipramine can be increased when it is combined with Prochlorperazine.
Thioridazine Thioridazine The serum concentration of Clomipramine can be increased when it is combined with Thioridazine.
Trifluoperazine Trifluoperazine The serum concentration of Clomipramine can be increased when it is combined with Trifluoperazine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Sulfadiazine Sulfadiazine Clomipramine may decrease the hypoglycemic activities of Sulfadiazine.
Oxycodone Oxycodone The metabolism of Clomipramine can be decreased when combined with Oxycodone.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Clomipramine.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Clomipramine.
Benztropine Benztropine The metabolism of Benzatropine can be decreased when combined with Clomipramine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Clomipramine.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Trihexyphenidyl Trihexyphenidyl Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The serum concentration of Clomipramine can be increased when it is combined with Perphenazine.
Azathioprine Azathioprine The metabolism of Clomipramine can be decreased when combined with Azathioprine.
Fluphenazine Fluphenazine The serum concentration of Clomipramine can be increased when it is combined with Fluphenazine.
Phentermine Phentermine The therapeutic efficacy of Clomipramine can be increased when used in combination with Phentermine.
Methylphenidate Methylphenidate The risk or severity of adverse effects can be increased when Methylphenidate is combined with Clomipramine.
Amoxapine Amoxapine The metabolism of Amoxapine can be decreased when combined with Clomipramine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Hydrocortisone Hydrocortisone The metabolism of Clomipramine can be increased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Clomipramine can be decreased when combined with Doxorubicin.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Carbamazepine Carbamazepine The serum concentration of Clomipramine can be increased when it is combined with Carbamazepine.
Molindone Molindone The risk or severity of adverse effects can be increased when Clomipramine is combined with Molindone.
Methyldopa Methyldopa The risk or severity of hypertension can be increased when Clomipramine is combined with Methyldopa.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Clomipramine.
Prazosin Prazosin Clomipramine may decrease the antihypertensive activities of Prazosin.
Hydralazine Hydralazine The metabolism of Hydralazine can be decreased when combined with Clomipramine.
Cimetidine Cimetidine The metabolism of Clomipramine can be decreased when combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Warfarin Warfarin The metabolism of Clomipramine can be increased when combined with Warfarin.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Clonazepam is combined with Clomipramine.
Loperamide Loperamide The metabolism of Clomipramine can be decreased when combined with Loperamide.
Promethazine Promethazine The serum concentration of Clomipramine can be increased when it is combined with Promethazine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Daunorubicin Daunorubicin The metabolism of Clomipramine can be decreased when combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Clomipramine can be increased when combined with Griseofulvin.
Digoxin Digoxin Digoxin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Clomipramine.
Chloroquine Chloroquine The metabolism of Clomipramine can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Clomipramine can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Clomipramine.
Calcitriol Calcitriol The metabolism of Clomipramine can be increased when combined with Calcitriol.
Triamterene Triamterene The metabolism of Clomipramine can be decreased when combined with Triamterene.
Sulfinpyrazone Sulfinpyrazone The metabolism of Clomipramine can be increased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide Clomipramine may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Clomipramine may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Clomipramine may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection Clindamycin Injection Clindamycin may increase the neurotoxic activities of Clomipramine.
Secobarbital Secobarbital The metabolism of Clomipramine can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Clomipramine can be decreased when combined with Desipramine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Clomipramine.
Imipramine Imipramine The metabolism of Clomipramine can be decreased when combined with Imipramine.
Probenecid Probenecid The metabolism of Clomipramine can be increased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Clomipramine.
Procainamide Procainamide The metabolism of Clomipramine can be decreased when combined with Procainamide.
Isoniazid Isoniazid The metabolism of Clomipramine can be decreased when combined with Isoniazid.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Rifampin Rifampin The metabolism of Clomipramine can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Disopyramide.
Valproic Acid Valproic Acid The metabolism of Clomipramine can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Clomipramine.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Clomipramine.
Levothyroxine Levothyroxine The risk or severity of Cardiac Arrhythmia and CNS stimulation can be increased when Levothyroxine is combined with Clomipramine.
Liothyronine Liothyronine The risk or severity of Cardiac Arrhythmia can be increased when Liothyronine is combined with Clomipramine.
Methimazole Methimazole The risk or severity of Cardiac Arrhythmia can be increased when Methimazole is combined with Clomipramine.
Propylthiouracil Propylthiouracil The risk or severity of Cardiac Arrhythmia can be increased when Propylthiouracil is combined with Clomipramine.
Chlorpropamide Chlorpropamide Clomipramine may decrease the hypoglycemic activities of Chlorpropamide.
Tolbutamide Tolbutamide Clomipramine may decrease the hypoglycemic activities of Tolbutamide.
Tolazamide Tolazamide Clomipramine may decrease the hypoglycemic activities of Tolazamide.
Dextromethorphan Dextromethorphan The metabolism of Clomipramine can be decreased when combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Clomipramine.
Niacin Niacin The metabolism of Clomipramine can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Clomipramine.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Clomipramine.
Clemastine Clemastine The metabolism of Clomipramine can be decreased when combined with Clemastine.
Chlorpheniramine Chlorpheniramine The metabolism of Clomipramine can be decreased when combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Clomipramine.
Meclizine Meclizine The metabolism of Clomipramine can be decreased when combined with Meclizine.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Hydrochlorothiazide.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Clomipramine.
Chlorzoxazone Chlorzoxazone The metabolism of Clomipramine can be decreased when combined with Chlorzoxazone.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Clomipramine.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Clomipramine.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Danazol Danazol The metabolism of Clomipramine can be decreased when combined with Danazol.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Clomipramine.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The serum concentration of Propranolol can be increased when it is combined with Clomipramine.
Minoxidil Minoxidil Clomipramine may decrease the antihypertensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine The therapeutic efficacy of Clomipramine can be increased when used in combination with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Clomipramine.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection The metabolism of Clomipramine can be decreased when combined with Amphotericin B.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Clomipramine.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Clomipramine.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Clomipramine.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Clomipramine.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Clomipramine.
Flavoxate Flavoxate Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Papaverine is combined with Clomipramine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Clomipramine can be decreased when combined with Fluorouracil.
Colchicine Colchicine The metabolism of Colchicine can be increased when combined with Clomipramine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Cephalexin Cephalexin The metabolism of Clomipramine can be decreased when combined with Cephalexin.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Dacarbazine Dacarbazine The metabolism of Clomipramine can be decreased when combined with Dacarbazine.
Acetazolamide Acetazolamide The metabolism of Clomipramine can be decreased when combined with Acetazolamide.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Clomipramine.
Ketoconazole Ketoconazole The metabolism of Clomipramine can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Clomipramine is combined with Pyrantel.
Thiotepa Injection Thiotepa Injection The metabolism of Clomipramine can be decreased when combined with Thiotepa.
Vincristine Injection Vincristine Injection Vincristine may increase the neurotoxic activities of Clomipramine.
Captopril Captopril Clomipramine may decrease the antihypertensive activities of Captopril.
Dipyridamole Dipyridamole The risk or severity of adverse effects can be increased when Dipyridamole is combined with Clomipramine.
Isoxsuprine Isoxsuprine The risk or severity of hypertension can be increased when Clomipramine is combined with Isoxsuprine.
Vinblastine Vinblastine The metabolism of Clomipramine can be increased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Metoprolol Metoprolol The metabolism of Clomipramine can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Clomipramine.
Thiothixene Thiothixene The risk or severity of adverse effects can be increased when Clomipramine is combined with Thiothixene.
Aspirin Aspirin The metabolism of Clomipramine can be increased when combined with Acetylsalicylic acid.
Salsalate Salsalate Clomipramine may decrease the excretion rate of Salsalate which could result in a higher serum level.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Clomipramine.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Clomipramine.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Clomipramine.
Dicyclomine Dicyclomine Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Clomipramine.
Propantheline Propantheline Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Clomipramine.
Nifedipine Nifedipine The metabolism of Clomipramine can be increased when combined with Nifedipine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Clomipramine.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Clomipramine.
Atenolol Atenolol The metabolism of Atenolol can be decreased when combined with Clomipramine.
Pindolol Pindolol The metabolism of Pindolol can be decreased when combined with Clomipramine.
Cisplatin Injection Cisplatin Injection Cisplatin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Bumetanide Bumetanide Bumetanide may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Streptozocin Streptozocin The metabolism of Clomipramine can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Clomipramine can be increased when combined with Etoposide.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Clomipramine.
Glipizide Glipizide Clomipramine may decrease the hypoglycemic activities of Glipizide.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Indapamide.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Dicloxacillin Dicloxacillin The metabolism of Clomipramine can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Clomipramine can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Pentoxifylline Pentoxifylline The metabolism of Clomipramine can be decreased when combined with Pentoxifylline.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Clomipramine.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Labetalol Labetalol The metabolism of Labetalol can be decreased when combined with Clomipramine.
Auranofin Auranofin Auranofin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Clomipramine.
Gemfibrozil Gemfibrozil The metabolism of Clomipramine can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Clomipramine.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Clomipramine.
Enalapril Enalapril Clomipramine may decrease the antihypertensive activities of Enalapril.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Amiodarone Amiodarone The metabolism of Clomipramine can be decreased when combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Buspirone Buspirone The metabolism of Clomipramine can be decreased when combined with Buspirone.
Lovastatin Lovastatin The metabolism of Clomipramine can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Clomipramine can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Diclofenac Diclofenac The metabolism of Clomipramine can be decreased when combined with Diclofenac.
Fluoxetine Fluoxetine The serum concentration of Clomipramine can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Clomipramine can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The metabolism of Clomipramine can be decreased when combined with Clozapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Estazolam is combined with Clomipramine.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Clomipramine.
Ofloxacin Ofloxacin The metabolism of Clomipramine can be decreased when combined with Ofloxacin.
Didanosine Didanosine Didanosine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Clarithromycin Clarithromycin The metabolism of Clomipramine can be decreased when combined with Clarithromycin.
Benazepril Benazepril Clomipramine may decrease the antihypertensive activities of Benazepril.
Etodolac Etodolac Etodolac may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Felodipine Felodipine The metabolism of Felodipine can be decreased when combined with Clomipramine.
Fosinopril Fosinopril Clomipramine may decrease the antihypertensive activities of Fosinopril.
Nabumetone Nabumetone The metabolism of Clomipramine can be decreased when combined with Nabumetone.
Quinapril Quinapril Clomipramine may decrease the antihypertensive activities of Quinapril.
Ramipril Ramipril Clomipramine may decrease the antihypertensive activities of Ramipril.
Simvastatin Simvastatin The metabolism of Clomipramine can be decreased when combined with Simvastatin.
Amlodipine Amlodipine Clomipramine may decrease the antihypertensive activities of Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Clomipramine can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Clomipramine can be decreased when combined with Itraconazole.
Lisinopril Lisinopril Clomipramine may decrease the antihypertensive activities of Lisinopril.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Rifabutin Rifabutin The metabolism of Clomipramine can be increased when combined with Rifabutin.
Sotalol Sotalol The metabolism of Clomipramine can be decreased when combined with Sotalol.
Bisoprolol Bisoprolol Clomipramine may decrease the antihypertensive activities of Bisoprolol.
Zolpidem Zolpidem Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Clomipramine.
Terazosin Terazosin Clomipramine may decrease the antihypertensive activities of Terazosin.
Isradipine Isradipine The metabolism of Isradipine can be decreased when combined with Clomipramine.
Omeprazole Omeprazole The metabolism of Omeprazole can be increased when combined with Clomipramine.
Cisapride Cisapride The metabolism of Clomipramine can be decreased when combined with Cisapride.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Clomipramine.
Fluvastatin Fluvastatin The metabolism of Clomipramine can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The metabolism of Clomipramine can be decreased when combined with Venlafaxine.
Stavudine Stavudine Stavudine may increase the neurotoxic activities of Clomipramine.
Famciclovir Famciclovir The metabolism of Clomipramine can be decreased when combined with Famciclovir.
Fluvoxamine Fluvoxamine The metabolism of Clomipramine can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Nefazodone can be decreased when combined with Clomipramine.
Lamotrigine Lamotrigine Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Clomipramine.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Tramadol Tramadol The risk or severity of serotonin syndrome can be increased when Clomipramine is combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Clomipramine can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Clomipramine.
Lansoprazole Lansoprazole The metabolism of Clomipramine can be increased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Clomipramine can be increased when combined with Ifosfamide.
Nicardipine Nicardipine The metabolism of Clomipramine can be decreased when combined with Nicardipine.
Bupropion Bupropion The risk or severity of seizure can be increased when Bupropion is combined with Clomipramine.
Ticlopidine Ticlopidine The metabolism of Clomipramine can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Clomipramine can be decreased when combined with Saquinavir.
Metformin Metformin Clomipramine may decrease the hypoglycemic activities of Metformin.
Nisoldipine Nisoldipine Clomipramine may decrease the antihypertensive activities of Nisoldipine.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Riluzole Riluzole The metabolism of Clomipramine can be decreased when combined with Riluzole.
Amifostine Injection Amifostine Injection The risk or severity of adverse effects can be increased when Amifostine is combined with Clomipramine.
Acarbose Acarbose Clomipramine may decrease the hypoglycemic activities of Acarbose.
Glimepiride Glimepiride Clomipramine may decrease the hypoglycemic activities of Glimepiride.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Ritonavir Ritonavir The serum concentration of Clomipramine can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Clomipramine can be decreased when combined with Docetaxel.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Zafirlukast Zafirlukast The metabolism of Clomipramine can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Mirtazapine Mirtazapine Clomipramine may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril Clomipramine may decrease the antihypertensive activities of Trandolapril.
Topiramate Topiramate The metabolism of Clomipramine can be increased when combined with Topiramate.
Zileuton Zileuton The metabolism of Clomipramine can be decreased when combined with Zileuton.
Valsartan Valsartan Clomipramine may decrease the antihypertensive activities of Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Clomipramine can be increased when combined with Insulin lispro.
Pramipexole Pramipexole Clomipramine may increase the sedative activities of Pramipexole.
Donepezil Donepezil The metabolism of Clomipramine can be decreased when combined with Donepezil.
Nelfinavir Nelfinavir The metabolism of Clomipramine can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The metabolism of Clomipramine can be decreased when combined with Azithromycin.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Clomipramine.
Nilutamide Nilutamide The metabolism of Clomipramine can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Clomipramine can be decreased when combined with Flutamide.
Selegiline Selegiline The metabolism of Clomipramine can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Clomipramine can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Clomipramine.
Propafenone Propafenone The metabolism of Clomipramine can be decreased when combined with Propafenone.
Letrozole Letrozole The metabolism of Clomipramine can be decreased when combined with Letrozole.
Raloxifene Raloxifene The metabolism of Clomipramine can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Clomipramine.
Tamsulosin Tamsulosin The metabolism of Clomipramine can be decreased when combined with Tamsulosin.
Ropinirole Ropinirole Clomipramine may increase the sedative activities of Ropinirole.
Finasteride Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Clomipramine.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Clomipramine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Clomipramine.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Clomipramine.
Tolcapone Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Clomipramine.
Citalopram Citalopram The serum concentration of Citalopram can be increased when it is combined with Clomipramine.
Capecitabine Capecitabine Capecitabine may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Efavirenz Efavirenz The metabolism of Clomipramine can be increased when combined with Efavirenz.
Abacavir Abacavir Abacavir may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Clomipramine can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone Clomipramine may decrease the hypoglycemic activities of Pioglitazone.
Celecoxib Celecoxib The metabolism of Clomipramine can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Clomipramine can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Clomipramine.
Thalidomide Thalidomide Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Clomipramine.
Galantamine Galantamine The metabolism of Clomipramine can be decreased when combined with Galantamine.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Clomipramine.
Rabeprazole Rabeprazole The metabolism of Rabeprazole can be decreased when combined with Clomipramine.
Terbinafine Terbinafine The metabolism of Clomipramine can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists